ShuYu Civilian Pharmacy Corp., Ltd. (SHE:301017)
China · Delayed Price · Currency is CNY 13.49
+0.15 (1.12%)
At close: May 8, 2026
SHE:301017 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 101.65 | 116.91 | -188.81 | 133.06 | 229.43 | 114.92 |
Depreciation & Amortization | 413.52 | 413.52 | 475 | 510.2 | 373.34 | 261.79 |
Other Amortization | 21.97 | 21.97 | 129.05 | 53.59 | 40.35 | 39.44 |
Loss (Gain) From Sale of Assets | -27.07 | -27.07 | -23.05 | -10.39 | -2.24 | 0.69 |
Asset Writedown & Restructuring Costs | -67.72 | -67.72 | 49.28 | 0.14 | 0.15 | 10.88 |
Loss (Gain) From Sale of Investments | 0.37 | 0.37 | -9.37 | -2.28 | -1.08 | -27.82 |
Provision & Write-off of Bad Debts | - | - | 14.29 | 23.08 | 19.86 | - |
Other Operating Activities | 108.37 | 126.91 | 157.27 | 140.33 | 78.81 | 31.38 |
Change in Accounts Receivable | -219.04 | -219.04 | -410.3 | -1,032 | -665.88 | -304.59 |
Change in Inventory | 163.25 | 163.25 | 269.96 | -148.77 | -498.4 | -293.93 |
Change in Accounts Payable | 301.38 | 301.38 | 114.41 | 500.5 | 580.86 | 419.74 |
Change in Other Net Operating Assets | -9.53 | -9.53 | - | -0 | - | - |
Operating Cash Flow | 769.11 | 802.91 | 489.32 | 142.91 | 148.44 | 237.53 |
Operating Cash Flow Growth | 53.06% | 64.09% | 242.40% | -3.73% | -37.50% | 1.29% |
Capital Expenditures | -153.35 | -172.4 | -173.54 | -181.55 | -110.45 | -136.6 |
Sale of Property, Plant & Equipment | 0.62 | 0.77 | 0.34 | 0.19 | 0.12 | 0 |
Cash Acquisitions | -507.26 | -460.77 | -146.31 | -298.48 | -161.98 | -348.72 |
Divestitures | 0.46 | 0.46 | - | - | - | -0.08 |
Investment in Securities | 14.9 | 9.43 | 87.31 | -491.18 | -19.04 | -280.99 |
Other Investing Activities | 131.16 | -31.84 | 2.59 | 5.19 | 5.92 | 0.13 |
Investing Cash Flow | -513.47 | -654.35 | -229.61 | -965.83 | -285.43 | -766.26 |
Short-Term Debt Issued | - | - | - | - | - | 115.29 |
Long-Term Debt Issued | - | 1,314 | 2,032 | 2,143 | 2,279 | 607.8 |
Total Debt Issued | 1,517 | 1,314 | 2,032 | 2,143 | 2,279 | 723.09 |
Long-Term Debt Repaid | - | -1,750 | -2,166 | -1,841 | -510.63 | -399.24 |
Total Debt Repaid | -1,764 | -1,750 | -2,166 | -1,841 | -510.63 | -399.24 |
Net Debt Issued (Repaid) | -246.76 | -436.26 | -133.84 | 302.72 | 1,768 | 323.85 |
Issuance of Common Stock | - | - | - | - | - | 299.37 |
Repurchase of Common Stock | - | - | -42.97 | - | - | - |
Common Dividends Paid | -90.94 | -90.27 | -103 | -107.08 | -69.89 | -55.72 |
Other Financing Activities | -88.12 | -39.16 | 2.52 | -53.7 | -376.66 | 10 |
Financing Cash Flow | -425.82 | -565.69 | -277.28 | 141.94 | 1,322 | 577.5 |
Foreign Exchange Rate Adjustments | 0 | 0 | 0.02 | -0.01 | - | - |
Net Cash Flow | -170.18 | -417.13 | -17.56 | -680.99 | 1,185 | 48.76 |
Free Cash Flow | 615.76 | 630.5 | 315.78 | -38.64 | 37.99 | 100.92 |
Free Cash Flow Growth | 73.78% | 99.67% | - | - | -62.35% | 149.36% |
Free Cash Flow Margin | 5.84% | 6.11% | 3.30% | -0.42% | 0.49% | 1.90% |
Free Cash Flow Per Share | 1.59 | 1.54 | 0.79 | -0.10 | 0.09 | 0.26 |
Cash Income Tax Paid | 325.21 | 320.78 | 306.71 | 296.98 | 226.08 | 224.91 |
Levered Free Cash Flow | 1,225 | 1,389 | 436.58 | 54.86 | 158.97 | 96.66 |
Unlevered Free Cash Flow | 1,225 | 1,389 | 523.37 | 128.82 | 204.86 | 116.65 |
Change in Working Capital | 218 | 218 | -114.34 | -704.81 | -590.18 | -193.75 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.